Jul 27, 2023 / 01:00PM GMT
Operator
Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the DiaSorin First Half 2023 Results Conference Call. (Operator Instructions)
At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead.
Carlo Rosa - DiaSorin S.p.A. - CEO, GM & Executive Director
Thank you, operator. Good morning, good afternoon, and welcome to the DiaSorin H1 conference call. As usual, I'm going to go through some comments about the business, and then I will allow the CFO, Mr. Pedron, to go through the numbers. As usual, I'm going to comment on the numbers at constant exchange rates.
So we had very good quarter. In the quarter, we had an acceleration of revenues compared to quarter 1. In fact, the quarter closed at plus 5% versus Q1 at plus 3%, as it is clearly excluding COVID. And I am going to now briefly comment the 3 legs for the way we look at the business in immunodiagnostics, molecular and the LTG. Let's start from the immunodiagnostics. The immunodiagnostic franchise, ex
Half Year 2023 DiaSorin SpA Earnings Call Transcript
Jul 27, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers